Thales Confirms Its Key Role to Provide Cybersecurity for Galileo Second Generation to Meet Tomorrow's Threats
20.7.2023 11:00:00 EEST | Business Wire | Press release
Europe’s largest satellite system security monitoring programme
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230720371000/en/
Sylvain Loddo - Head of Galileo Ground Segment Management Office, Ennio Guarino - Head of Galileo and EGNOS Programme Department, Lionel SALMON – Cybersecurity of Information Systems Director and Alexandra POREZ – Thales GALILEO Programme Director. ©Thales
As part of G2G IOV SECMON, Thales is leading the consortium, including the Italian group Leonardo, to expand the scope of security monitoring and include the new assets in the G2G system. It will also introduce automated incident response and network traffic monitoring. In addition, the solution will be capable of storing significant amounts of incident response data. To meet this challenge, Thales will deliver a solution built on a scalable, flexible architecture derived from its Cybels range of security supervision products and incorporating big data capabilities.
A cybersecurity contract for better protection from quantum threats
New threats from quantum computers capable of breaking existing cryptographic algorithms have the potential to compromise long-term data security. Thales has been tasked by ESA within the consortium it leads to draw on its world-renowned cryptography expertise.
Under the “G2G System Engineering and Technical Assistance for security and PRS” contract, Thales will specify and verify the new cybersecurity for the G2G system – taking into account new threats to space systems, security maintenance requirements, improvements to the PRS service for government users– and prepare for system certification. One of the major challenges is to ensure a smooth transition from G1G to G2G while maintaining the level of security and performance offered by the G1G system for member states.
“Thales thanks ESA, EUSPA and the European Commission for its continued confidence in the Group’s expertise in space systems and cybersecurity for critical systems. These security contracts for Galileo Second Generation will bring Europe a more robust system with better protection from quantum threats – a major challenge for the space industry in the decades ahead – and will draw on the Group’s unparalleled big data expertise to provide more effective security monitoring of the world’s leading satellite positioning system,” said Pierre-Yves Jolivet, VP Cyber Solutions, Thales.
The cybersecurity of satellite systems has become a growing concern for satellite operators and space agencies, particularly against a backdrop of geopolitical tensions. Today, thousands of satellites are in orbit, and it is estimated that 10,000 more will be added over the next 10 years, due to the multiplication of uses, from everyday life with the Internet of Things to defense applications.
Through the signing of these two contracts, Thales's expertise in scalable and flexible architecture and security equipment and protection against cyberattacks will enable the G2G program to strengthen its ability to detect and respond to new cyberthreats. The end-to-end solution proposed by Thales experts will contribute to the development of greater security and resilience of satellites.
In parallel, Thales Alenia Space has been notified of major contracts to design and build with its European consortium the G2G Ground Mission Segment and execute System Engineering Activities. The company is also providing 6 of the 12 satellites of the constellation.
Cybersecurity at Thales
As a global leader in cybersecurity, Thales is involved at every level of the cyber value chain, offering solutions ranging from risk assessment to protection of critical infrastructure, supported by comprehensive threat detection and response capabilities. Its offer is built around three families of cybersecurity products and services, which generated sales of €1.5bn in 2022:
- Global security products around the CipherTrust Data Security Platform the SafeNet Trusted Access Identity & Access Management as a service solution, and the broader cloud protection & licensing offerings
- Sovereign protection products including encryptors and sensors to protect critical information systems
- Cybels solutions portfolio, a complete suite of cybersecurity services including risk assessment, training and simulation, and cyberattack detection and response
Drawing on more than 40 years of experience in cybersecurity and space activities, Thales applies the principles of "cybersecurity by design" to the products it develops for satellite operators and space agencies. With more than 4,000 cybersecurity specialists, Thales helps to ensure the security of satellite systems for national and European space programmes – in particular Europe's Galileo satellite navigation programme – and at the international level. With its combined expertise in cutting-edge satellite systems and cybersecurity solutions relying on the latest military technologies, Thales offers governments, institutions and enterprise customers a comprehensive range of cybersecurity solutions to guarantee robust protection of all the elements of a space system. In April 2023, Thales demonstrated its expertise in offensive security at CYSAT, managing to take remote control of an ESA demonstration satellite, in order to anticipate and respond to current and future threats.
About Galileo
Galileo is Europe’s global navigation satellite system (GNSS). Operational since 15 December 2016, Galileo’s initial services are fully interoperable with GPS, while offering users an expanded range of performance and service levels, along with far more accurate positioning. All smartphones sold in the European Single Market are now guaranteed Galileo-enabled. In addition, Galileo is making a difference across the fields of rail and maritime transportation, agriculture, financial timing services and rescue operations. Unlike the American GPS, Russian GLONASS and Chinese Beidou satellite navigation systems, which are operated by the armed forces, Galileo is the world’s only GNSS system under civilian control.
To date, Galileo is scheduled to comprise a constellation of 38 first-generation satellites, transmitting stations for satellite control and telemetry, transmitting stations for mission data, two security management centres (in Saint-Germain-en-Laye and Madrid), two system control centres (Oberpfaffenhofen and Fucino) and 16 stations for orbit control and clock synchronisation.
Galileo Second Generation is designed to be flexible and adapt to user needs in the decades ahead. It will also be more robust to withstand the challenges of a constantly changing world, especially the threats of jamming and cybercrime. With unrivalled accuracy and additional authentication capabilities, Galileo will be the world’s most advanced GNSS system.
|
About Thales Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive. The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity. Thales has 77,000 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.
|
More information:
Cybersecurity solutions | Thales Group
Cybersecurity in space: How Thales is meeting the challenges ahead | Thales Group
Cyberthreat hitmap (thalesgroup.com)
1 « Public Regulated Service » refers to Galileo’s service for governmental use
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230720371000/en/
Contact information
PRESS CONTACTS
Thales Media Relations
Marion Bonnet
+33 (0)6 60 38 48 92
marion.bonnet@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
